Cortical spheroid on perfusable microvascular network in a microfluidic device
PLOS ONE · 19.10.2023 · 18 (10) · e0288025
DOI: 10.1371/journal.pone.0288025 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 19.10.2023. Verfasst von Teal Russell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fostering Innovation Through Biosystems for Enhanced Scientific Technologies (FIT BEST) Laboratory, Department of Chemical, Biological, and Bio Engin…. Hauptthemen laut MEDLINE: Endothelial Cells, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Division of Civil, Mechanical and Manufacturing Innovation, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Human induced pluripotent stem cell (hiPSC)-derived brain spheroids can recapitulate the complex cytoarchitecture of the brain, as well as the genetic/epigenetic footprint of human brain development. However, hiPSC-derived 3D models such as spheroid and organoids does not have a perfusable microvascular network, which plays a vital role in maintaining homeostasis in vivo . With the critical balance of positive and negative angiogenic modulators, 3D microvascular network can be achieved by angiogenesis. This paper reports on a microfluidic-based three-dimensional, cortical spheroid grafted on the vascular-network. Vascular network was formed by inducing angiogenic sprouting using concentration gradient-driven angiogenic factors in the microfluidic device. We investigate critical factors for angiogenic vascular network formation with spheroid placement, including 1) a PKCα activator, phorbol-12-myristate-13-acetate (PMA); 2) orientation of endothelial cells under perfusion and permeability of vascular network; 3) effect of extracellular matrix (ECM) types and their densities on angiogenesis; and 4) integration with cortical spheroid on vascular network. This paper demonstrates proof of concept for the potential utility of a membrane-free in vitro cortical spheroid tissue construct with perfusable microvascular network that can be scaled up to a high throughput platform. It can provide a cost-effective alternative platform to animal testing by modeling brain diseases and disorders, and screening drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Fostering Innovation Through Biosystems for Enhanced Scientific Technologies (FIT BEST) Laboratory, Department of Chemical, Biological, and Bio Engineering, College of Engineering, North Carolina A&T State University, G…
- Chemical & Biomedical Engineering, College of Engineering, Florida A&M University-Florida State University, Tallahassee, FL, United States of America.
- MIMETAS, BV, DH Oegstgeest, The Netherlands.
- Department of Neurology, Duke University Medical Center, Durham, NC, United States of America.
ORCID-Profile: Yeoheung Yun
Förderung
- NINDS NIH HHS
- Division of Civil, Mechanical and Manufacturing Innovation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Russell, T., Dirar, Q., Li, Y., Chiang, C., Laskowitz, D. T., & Yun, Y. (2023). Cortical spheroid on perfusable microvascular network in a microfluidic device. PLOS ONE, 18(10), e0288025. https://doi.org/10.1371/journal.pone.0288025
Vancouver
Russell T, Dirar Q, Li Y, Chiang C, Laskowitz DT, Yun Y. Cortical spheroid on perfusable microvascular network in a microfluidic device. PLOS ONE. 2023;18(10):e0288025. doi:10.1371/journal.pone.0288025
BibTeX
@article{Russell2023,
author = {Russell, Teal and Dirar, Qassim and Li, Yan and Chiang, Chiwan and Laskowitz, Daniel T and Yun, Yeoheung},
title = {Cortical spheroid on perfusable microvascular network in a microfluidic device},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {10},
pages = {e0288025},
doi = {10.1371/journal.pone.0288025}
}
EUVIMED